SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

American Renal Associates Holdings, Inc. – ‘10-Q’ for 6/30/17

On:  Tuesday, 8/8/17, at 4:48pm ET   ·   For:  6/30/17   ·   Accession #:  1498068-17-71   ·   File #:  1-37751

Previous ‘10-Q’:  ‘10-Q’ on 5/9/17 for 3/31/17   ·   Next:  ‘10-Q’ on 11/14/17 for 9/30/17   ·   Latest:  ‘10-Q’ on 11/6/20 for 9/30/20

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/08/17  American Renal Assocs Holdin… Inc 10-Q        6/30/17   72:8.9M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    678K 
 2: EX-10.1     Material Contract                                   HTML     65K 
 3: EX-10.2     Material Contract                                   HTML   1.56M 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
14: R1          Document and Entity Information                     HTML     41K 
15: R2          Consolidated Balance Sheets                         HTML    115K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     44K 
17: R4          Consolidated Statements of Operations               HTML     93K 
18: R5          Consolidated Statements of Comprehensive (Loss)     HTML     36K 
                Income                                                           
19: R6          Consolidated Statement of Changes in Equity         HTML     76K 
20: R7          Consolidated Statements of Cash Flows               HTML    136K 
21: R8          Basis of Presentation and Organization              HTML     39K 
22: R9          Initial Public Offering                             HTML     42K 
23: R10         Cash                                                HTML     29K 
24: R11         Accounts Receivable                                 HTML     28K 
25: R12         Fair Value Measurements                             HTML     91K 
26: R13         Accrued Expenses and Other Current Liabilities      HTML     39K 
27: R14         Variable Interest Entities                          HTML     29K 
28: R15         Noncontrolling Interests Subject to Put Provisions  HTML     68K 
29: R16         Debt                                                HTML     63K 
30: R17         Income Taxes                                        HTML     28K 
31: R18         Stock-Based Compensation                            HTML     73K 
32: R19         Loss Per Share                                      HTML     79K 
33: R20         Related Party Transactions                          HTML     37K 
34: R21         Commitments and Contingencies                       HTML     28K 
35: R22         Certain Legal Matters                               HTML     36K 
36: R23         Changes in Ownership Interest in Consolidated       HTML     68K 
                Subsidiaries                                                     
37: R24         Basis of Presentation and Organization (Policies)   HTML     41K 
38: R25         Cash (Tables)                                       HTML     34K 
39: R26         Fair Value Measurements (Tables)                    HTML     83K 
40: R27         Accrued Expenses and Other Current Liabilities      HTML     40K 
                (Tables)                                                         
41: R28         Noncontrolling Interests Subject to Put Provisions  HTML     44K 
                (Tables)                                                         
42: R29         Debt (Tables)                                       HTML     47K 
43: R30         Stock-Based Compensation (Tables)                   HTML     72K 
44: R31         Loss Per Share (Tables)                             HTML     77K 
45: R32         Changes in Ownership Interest in Consolidated       HTML     43K 
                Subsidiaries (Tables)                                            
46: R33         Basis of Presentation and Organization (Details)    HTML     51K 
47: R34         Initial Public Offering (Details)                   HTML    114K 
48: R35         Cash (Details)                                      HTML     29K 
49: R36         Accounts Receivable (Details)                       HTML     30K 
50: R37         Fair Value Measurements (Details)                   HTML     29K 
51: R38         Fair Value Measurements - Schedule of fair values   HTML     69K 
                (Details)                                                        
52: R39         FAIR VALUE MEASUREMENTS - Fair value rollforward    HTML     29K 
                for tax receivable agreement liability (Details)                 
53: R40         Accrued Expenses and Other Current Liabilities      HTML     45K 
                (Details)                                                        
54: R41         Variable Interest Entities (Details)                HTML     24K 
55: R42         Noncontrolling Interests Subject to Put Provisions  HTML     49K 
                (Details)                                                        
56: R43         DEBT - Schedule of long-term debt (Details)         HTML     41K 
57: R44         DEBT - Scheduled maturities of long-term debt       HTML     39K 
                (Details)                                                        
58: R45         DEBT - Narrative (Details)                          HTML    106K 
59: R46         Income Taxes (Details)                              HTML     28K 
60: R47         STOCK-BASED COMPENSATION - Schedule of Expense      HTML     31K 
                (Details)                                                        
61: R48         STOCK-BASED COMPENSATION - Narrative (Details)      HTML     48K 
62: R49         STOCK-BASED COMPENSATION - Assumptions used for     HTML     35K 
                options granted (Details)                                        
63: R50         STOCK-BASED COMPENSATION - Option activity          HTML     54K 
                (Details)                                                        
64: R51         STOCK-BASED COMPENSATION - Restricted stock awards  HTML     45K 
                (Details)                                                        
65: R52         Loss Per Share (Details)                            HTML     57K 
66: R53         Related Party Transactions (Details)                HTML     60K 
67: R54         Commitments and Contingencies (Details)             HTML     22K 
68: R55         Certain Legal Matters (Details)                     HTML     28K 
69: R56         Changes in Ownership Interest in Consolidated       HTML     35K 
                Subsidiaries (Details)                                           
71: XML         IDEA XML File -- Filing Summary                      XML    122K 
70: EXCEL       IDEA Workbook of Financial Reports                  XLSX     74K 
 8: EX-101.INS  XBRL Instance -- ara-20170630                        XML   1.36M 
10: EX-101.CAL  XBRL Calculations -- ara-20170630_cal                XML    217K 
11: EX-101.DEF  XBRL Definitions -- ara-20170630_def                 XML    488K 
12: EX-101.LAB  XBRL Labels -- ara-20170630_lab                      XML   1.47M 
13: EX-101.PRE  XBRL Presentations -- ara-20170630_pre               XML    833K 
 9: EX-101.SCH  XBRL Schema -- ara-20170630                          XSD    137K 
72: ZIP         XBRL Zipped Folder -- 0001498068-17-000071-xbrl      Zip    188K 




        
Filing Submission 0001498068-17-000071 – SGML Text

Original SGML Text submitted by:  American Renal Associates Holdings, Inc.

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 2, 7:45:40.1pm ET